glp-1 in europe Uptake by Country: Where Ozempic and Mounjaro are Booming 2026 GLP-1s in the spotlight at

All preclinical studies and scientific literature cited on this page are provided for educational purposes to illustrate laboratory research trends

The underlying compounds are well studied GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide, and the dual agonist tirzepatide, examined in STEP ( NEJM , 2021), SURMOUNT (NEJM 2022), and SURMOUNT-OSA (NEJM 2024) but a legitimate program is defined by how responsibly it prescribes them, not merely that it offers them

[Common Side Effects & How to Prevent Them]

Researchers found that exercise and GLP-1 therapy could generate $182 million in health and economic value for Australia over the next 10 years